Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: Role of natural killer T cells

Transplantation

Volumn 85, Issue 4, 2008, Pages 607-614

  Liu, Yin Ping ^a   Li, Zengqi ^a,b   Nador, Roland G ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Mixed chimerism; Organ transplantation; T cell subsets

Indexed keywords

CD1 ANTIGEN;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; IMMUNOLOGY; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; RADIATION EXPOSURE; WHOLE BODY RADIATION;

ANIMALS; ANTIGENS, CD1; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEART TRANSPLANTATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 44449100774     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816361ce     Document Type: Article

References (32)

1. Monaco A, Wood P, Russel ML, Russel PS. Studies on heterologous anti-lymphocyte serum in mice. III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum. Annls NY Acad Sci 1966; 129: 190.
2. Field EH, Strober S. Tolerance, mixed chimerism and protection againstGVHDafter TLI. Philos Trans R Soc Lond B Biol Sci 2001; 356: 1.
3. Sykes M, Sachs DH. Mixed chimerism. Philos Trans R Soc Lond B Biol Sci 2001; 356: 707.
4. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001; 14: 417.
5. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037.
6. Higuchi M, Zeng D, Shizuru J, et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 2002; 169: 5564.
7. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 1087.
8. Nikolic B, Lei H, Pearson DA, et al. Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat→mouse bone marrow chimeras. Transplantation 1998; 65: 1216.
9. Bigenzahn S, Blaha P, Koporc Z, et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005; 5: 1237.
10. Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756.
11. Diaconescu R, Flowers CR, Storer B, et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550.
12. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756.
13. Khouri IF, Keating M, Korbling M, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817.
14. Fudaba Y, Spitzer TR, Shaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am J Transplant 2006; 6: 2121.
15. Lan F, Zeng D, Higuchi M, et al. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "Natural suppressor" cells. J Immunol 2001; 167: 2087.
16. Bendelac A. Positive selection of mouse NK1+T cells by CD1-expressing cortical thymocytes. J Exp Med 1995; 182: 2091.
17. Kronenberg M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu Rev Immunol 2005; 23: 877.
18. Zeng D, Lewis D, Dejbakhsh-Jones S, et al. Bone marrow NK1.1(+) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999; 189: 1073.
19. Hashimoto D, Asakura S, Miyake S, et al. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J Immunol 2005; 174: 551.
20. Morecki S, Panigrahi S, Pizov G, et al. Effect of KRN7000 on induced graft-vs-host disease. Exp Hematol 2004; 32: 630.
21. Haraguchi K, Takahashi T, Matsumoto A, et al. Host-residual invariantNKT cells attenuate graft-versus-host immunity. J Immunol 2005; 175: 1320.
22. Smiley ST, Kaplan MH, Grusby MJ. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997; 275: 977.
23. Cui J, Shin T, Kawano T, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623.
24. Trager DK, Banks BA, Rosenbaum GE, et al. Cardiac allograft prolongation in mice treated with combined posttransplantation total-lymphoid irradiation and anti-L3T4 antibody therapy. Transplantation 1989; 47: 587.
25. Slavin S, Strober S, Fuks Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977; 146: 34.
26. Slavin S, Fuks Z, Kaplan HS, Strober S. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J Exp Med 1978; 147: 963.
27. Lan F, Zeng D, Higuchi M, et al. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: The role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant 2003; 9: 355.
28. Fauci AS. Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. J Clin Invest 1975; 56: 98.
29. Lowsky R, Takahashi T, Liu YP, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005; 353: 1321.
30. Martin PJ, Kernan N. T cell depletion for GVHD prevention in humans. In: Graft Versus Host Disease: Research and Clinical Management. New York: Marcel Dekker; 1990: 371.
31. Burnett AK, Hann IM, Robertson AG, et al. Prevention of graft-versushost disease by ex vivo T cell depletion: Reduction in graft failure with augmented total body irradiation. Leukemia 1988; 2:
32. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism following combined renal and hematopoietic cell transplants. N Engl J Med 2008 in press.